Enterococcus spp.
Introduction
Enterococci have progressively appeared as a reason for severe nosocomial and community acquired infections, such as endocarditis and bacteremia in worldwide (1) . This variant is also are normal floras of human and animals digestive system. Therefore known as occasional human pathogens responsible for community-acquired and nosocomial infections (2) . Common treatment regiments include a penicillin or a glycopeptide with an aminoglycoside, most usually gentamicin (3) . The efficiency of this choice has been challenged by appearance of enterococcus strains showing multiple antibiotic resistance, especially those agents' aminoglycosides, penicillin's and glycopeptides (4) . Its resistance to wider range of antimicrobial agents particularly, aminoglycosides, glycopeptides and beta-lactams has increasingly been documented (5) .
All enterococci have intrinsic low-level resistance to aminoglycosides, with minimal inhibitory concentrations (MICs) ranging from 4-256 mg/mL. This level of resistance is the result of facultative anaerobic metabolism of enterococci and limited drug uptake (6) . High-level aminoglycoside resistance (HLAR) (MIC, ≥512 µg/ml) in enterococci was first detected in 1980s. They have been then detected with increasing frequency in specimens from hospitalized patients, and in the intestinal tract of humans and animals (7) . HLAR in enterococci is mediated by aminoglycoside-modifying enzymes (AMEs), which remove the synergic bactericidal effect between anti-cell wall agents, including b-lactams or glycopeptides and aminoglycosides, such as gentamicin, tobramycin, netilmicin, kanamycin and amikacin (1) . The most common AMEs in Enterococcus spp. are the AAC (6ʹ) (aminoglycoside acetyltransferase), -APH (2ʹʹ) (aminoglycoside phosphotransferase), which inactivates gentamicin, kanamycin, tobramycin, netilmicin and amikacin; APH (3ʹ), which inactivates kanamycin and amikacin; ANT (4ʹ) (aminoglycoside nucleotidyltransferase or adenylyltransferase), which inactivates kanamycin, amikacin and tobramycin; and ANT (6ʹ), that inactivates streptomycin. Furthermore, E. faecium strains produce a chromosomally encoded aminoglycoside acetyltransferase, AAC (6ʹ)-Ii, that inactivates tobramycin, netilmicin, kanamycin and sisomicin (8) .
Epidemiologic studies which detected the presence of aac (6ʹʹ)-Ie, aph (2ʹʹ)-Ia, aph (2ʹʹ)-Ib, aph (2ʹʹ)-Ic, and aph (2ʹʹ)-Id genes in clinical and animal enterococcus isolates have either used single PCR primer pair for each gene in separate reactions or, at greatest, used PCR primers for two of these gentamicin resistance genes in one reaction (9).
Objectives
This study aimed to investigate the true prevalence of high level aminoglycoside resistance (HLAR) strains among clinically important isolates of enterococcal strains and to examine susceptibility of E. faecalis and to various antimicrobial agents including ampicillin (10µg), penicillin (10µg), gentamicin (10µg), streptomycin (10µg), vancomycin (30µg), ciprofloxacin (5µg), nitrofurantoin (300-μg) and tetracycline (30µg 
Antimicrobial susceptibility tests
Susceptibility tests were performed by disc diffusion method on the Mueller-Hinton Agar (Merck Co., Germany) plates according to Clinical and Laboratory Standards Institute (CLSI) guideline (27) for the following antibiotics: ampicillin (10µg), penicillin (10µg), gentamicin (10µg), streptomycin (10µg), vancomycin (30µg), ciprofloxacin (5µg), nitrofurantoin (300-μg) and tetracycline (30µg used as reference strain for antibiotic susceptibility testing.
Minimum Inhibitory Concentration for HLAR
The samples were confirmed as high level aminoglycoside resistant (HLAR) enterococci by considering growth ≥512 μg/mL for gentamicin and ≥1024 μg/mL for streptomycin. The 18h bacterial cultures were adjusted to 0.5 McFarland's turbidity and the inoculum was spot inoculated on the surface of BHI agar with increasing concentrations of gentamicin and streptomycin antibiotics (Merck Co., Germany). The plates were incubated at 37°C for 24 hrs and inspected for more than one colony forming units in the patterned area. E.faecalis ATCC 29212 was used as a negative control strain.
Multiplex-PCR for Analysis of Aminoglycoside Modifying Genes
Multiplex-PCR was done using the DNA amplification instrument master cycler gradient (Eppendorf, Germany) for detection of the aac(6ʹ)-
Ie -aph(2ʹʹ)-Ia , aph(3ʹ)-IIIa, ant(4ʹ)-Ia genes.
Genomic DNA were obtained from E. faecalis colonies grown overnight on blood agar (Merck Co., Germany) plates by DNA extraction kit (Bioneer Co., Korea) according to manufacturer's instruction. Specific primer pairs for amplification of these genes are listed in Table 1 (10) . A volume of 1.5 µl of extracted genomic DNA (20 ng) was added to Master mix (Amplicon Co., Denmark) including 2.5 µl of 10X PCR buffer, 1.5 µl MgCl2 (50 mM), 0.5 µl dNTPs (10 mM), 1.25 µl of each primer (10 pmol), 0.5 µl of Taq DNA polymerase (5 U/µl) and 16 µl sterile distilled watern, a total volume of 25 µl PCR reaction mixture. The reaction mixture was performed in a thermal gradient cycler (Eppendorf, Germany) with the denaturation at 94°C for 4 min, 30 cycles with denaturation at 94°C for 31 s, annealing at 52°C for 31 s, extension at 72°C for 45 s and final extension at 72°C for 5 min. PCR products were analyzed by electrophoresis in 1.5% agarose gel. Staphylococcus aureus ATCC 29213 was used as a negative control for M-PCR therefore DNAs from E. faecium SF11770, E. faecalis WBH18190 used as positive controls.
Statistical analysis
Results were analyzes as negative or positive polymerase chain reaction amplification reaction for each bacteria, as well as 2 bacteria simultaneously. Descriptive analysis were performed and results presented as number (%). Also Statistical evaluation of the result of antibiotic sensitivity test was done using 'Z' test for proportions. P value was measured by the χ2 and ANOVA test with Yates' correction
Results

Bacterial isolates
A total of 84 Enterococcus strains were isolated from the different clinical samples, including; urine, wound, sputum, abscess and tissues. Respectively 60% and 40% of the samples were obtained from women and men. Most isolates (n=66, 66%) were recovered from urine samples. various species of Enterococcus were isolated in all, 70 samples (83.3%) E. faecalis and 14 samples (16%) E. faecium isolates were detected, respectively (Diagram 2). The male-female ratio was 1.25:1. Age distribution show in diagram 2.
Antibiotic Resistance Profiles
Kirby-Bauer antibiotic tests were performed for the E. faecalis isolates which indicated the percentage of resistance to ampicillin, penicillin, gentamicin, streptomycin, vancomycin, ciprofloxacin, nitrofurantoin and tetracycline were 9%, 12%, 43%, 47 %, 7%, 39%, 1% and 84%, respectively (Diagram 2). The highest and lowest resistance rates were towards tetracycline and nitrofurantoin with 84% and 1% frequency, respectively. Except for one strain, all E. faecalis isolates were susceptible to nitrofurantoin. The results of high-level gentamicin and streptomycin resistance test in E. faecalis showed 33 (44%), 5 (5.9%), 45 (53.5%) were sensitive (S), intermediate (I) and resistance (R) to gentamicin and 32 (38%), 5 (5.9%) and 47 (55.9%) were S, I and R to streptomycin, respectively. High-level resistance test in E. faecium revealed 3 (18.7%) and 7 (43.7%) were I and 13 (81.2%) and 9 (56.2%) were R to gentamicin and streptomycin, respectively. We did not find any gentamicin and streptomycin sensitive E.faecium strains.
MIC for HLAR
Aminoglycoside antibiotics are considered efficient in treating serious infections caused by both gram negative and gram positive bacteria. Due to acquisition of extrinsic resistance to high level aminoglycoside antibiotics in enterococci, these strains gain importance in clinical settings. A total of 84 enterococcal isolates were separated by MIC method, 35/84 (~43%) were HLGR (MIC ≥ 512 μg/mL) for gentamicin and 28/84 (~30%) were HLSR (MIC ≥ 1024 μg/mL) for streptomycin. Although the present study revealed HLSR strains.
4.4.
Multiplex-PCR Analysis of Aminoglycoside Modifying Genes Rsults
All 84 enterococcal isolates were analyzed for the presence of aminoglycoside modifying enzyme coding genes.
Identification of aminoglycoside resistance genes was accomplished by detection of aac(6ʹ)-Ie -aph(2ʹʹ)-Ia , aph(3ʹ)-IIIa, ant(4ʹ)-Ia genes in the E. faecalis strains by Multiplex PCR method. The distribution of aac (6ʹ)-Ie -aph (2ʹʹ)-Ia, ant (4ʹ)-Ia, aph (3ʹ)-
IIIa genes were 59%, 30%, and 49%, respectively (Diagram 3). The PCRamplified DNA products of these genes are shown in figure 1.
Discussion
In the meantime early 1970s, Enterococci were considered as nosocomial pathogens. The character of enterococci as a causal agent of numerous infections has become noticeably significant, not only for their known pathogenic potential but also due to increasing antimicrobial resistance (11, 12). The prevalence of E. faecalis and E. faecium, is approximately 75% and 20% of all enterococcal-related infections, respectively (13). In this study, 84 Enterococcus strains were collected from urine, wound, ascites, biopsy, CSF, pleura, sputum, synovial fluid, BAL, prostate, testes, blood, vagina, sinus secretions, placenta, pericardium and abscess specimens (100 samples). The frequency of E. faecalis and E. faecium isolation rate were 16% and 70 samples (83.3%), respectively. Out of 16 E. faecium strains, 6 and 10 isolates were obtained from men and women, respectively. Of the 70 E. faecalis strains, 28 and 42 isolates were collected from male and female patients, respectively. ANOVA statistical analysis showed that there was a significant difference between Enterococcal infections and patients sex, with women being more infected than men (P<0.05). Gordon et al also showed Enterococci infections are similarly disseminated between sexes and urinary tract infections are more common in healthy women than men. (14, 15) . This results according to our information.
Indiscriminate use of antibiotics such as aminoglycoside, cephalosporin, aztreonam, trimethoprim and other antibiotics has resulted in increased entrococcal infections (16) . Antibiotic susceptibility test showed 75%, 42%, 72%, 82%, 11% and 7% of the isolates were sensitive to vancomycin, ciprofloxacin, penicillin, nitrofurantoin, gentamicin and streptomycin, respectively. The highest resistance rate (84%) was related to tetracycline. High level gentamicin resistance is mainly due to the presence of functional enzyme aac(6′)-Ie-aph(2′′)-Ia which also confers high level resistance to tobramycin, kanamycin, amikacin, dibekacin, and netilmicin not including streptomycin (17).
Aminoglycosides are commonly used in synergy with anti-cell wall agents for severe enterococcal infections such as endocarditis and bacteremia. The synergic effect is a result of disruption of bacterial cell wall by the B-lactam antibiotic which permits the aminoglycoside to enter and apply their bactericidal effects (18, 19). The loss of synergistic effect between aminoglycosides and cell wall active agents has caused problems in selecting suitable treatment for HLAR infections. This outcome lead to a lack of satisfactory treatment of HLAR enterococci. Lowlevel aminoglycoside resistance is an inherent characteristic in all enterococcal species; although, HLAR can occur due to numerous AMEs (20, 21) . In this study, HLGR was observed in 33 E. faecalis strains (50%) which was consistent and similar with the reported by Behnood (1) . The contrast may be due to the expression of genes other than genes analyzed in this study. HLAR genes are located on plasmids and most frequently on conjugative transposons which can lead to horizontal transfer of resistance factors (28).
6• Conclusions
In conclusion we had observed enterococci isolates with phenotypic resistance to high level gentamicin and demonstrated aac(6′)-Ie-aph(2′′)-Ia and aph(3′)-IIIa genes more frequently occurring than other genes. A collection of AMEs are accountable for HLAR status among Enterococcus species. The aac (6ʹ)-Ie-aph (2ʹʹ)-Ia gene was detected more frequently than the other genes. This highlights the limited gene spreading and transfer of resistant genes within a geographical region. Henceforth, surveillance studies can be conducted among Enterococcus isolates from various sources in any given geographical region to document the AME gene patterns. Recent studies also indicated HLGR to be more common in all species of enterococci than HLSR.
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